Isolate-dependent use of claudins for cell entry by hepatitis C virus

Hepatology

Volumn 59, Issue 1, 2014, Pages 24-34

  Haid, Sibylle ^a   Grethe, Christina ^a   Dill, Michael T ^b   Heim, Markus ^b   Kaderali, Lars ^c   Pietschmann, Thomas ^a  

^a INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; CLAUDIN; CLAUDIN 1; CLAUDIN 6; MESSENGER RNA; NEUTRALIZING ANTIBODY; OCCLUDIN; SCAVENGER RECEPTOR BI; ANTIBODY; CLDN1 PROTEIN, HUMAN;

ARTICLE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL TROPISM; VIRUS ENTRY; VIRUS ISOLATION; VIRUS STRAIN; BIOPSY; CELL STRAIN HEK293; IMMUNOLOGY; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANTIBODIES; BIOPSY; CELL LINE, TUMOR; CLAUDIN-1; CLAUDINS; HEK293 CELLS; HEPACIVIRUS; HUMANS; LIVER; RNA, MESSENGER; VIRAL TROPISM; VIRUS INTERNALIZATION;

EID: 84894626680     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26567     Document Type: Article

References (14)

1. Lemon SM, Walker CM, Alter MJ, Yi M. Hepatitis C virus. In: Knipe DM, Howley PM, eds. Fields Virology. Vol. 5. Philadelphia, PA: Lipincott Williams & Wilkins; 2007:1253-1304.
2. Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int 2012;32:339-345.
3. Seeff LB, Hoofnagle JH. National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. Hepatology 2002;36:S1-S2.
4. Negro F. Hepatitis C virus-induced steatosis: an overview. Dig Dis 2010;28:294-299.
5. Zeisel MB, Felmlee DJ, Baumert TF. Hepatitis C virus entry. Curr Top Microbiol Immunol 2013;369:87-112.
6. Zheng A, Yuan F, Li Y, Zhu F, Hou P, Li J, et al. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus. J Virol 2007;81:12465-12471.
7. Meertens L, Bertaux C, Cukierman L, Cormier E, Lavillette D, Cosset FL, Dragic T. The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus. J Virol 2008;82:3555-3560.
8. Haid S, Windisch MP, Bartenschlager R, Pietschmann T. Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line. J Virol 2010;84:964-975.
9. Haid S, Novodomska A, Gentzsch J, Grethe C, Geuenich S, Bankwitz D, et al. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. Gastroenterology 2012;143:213-222.e5.
10. Gottwein JM, Scheel TK, Jensen TB, Lademann JB, Prentoe JC, Knudsen ML, et al. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 2009;49:364-377.
11. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005;309:1577-1581.
12. Hotzel I, Chiang V, Diao J, Pantua H, Maun HR, Kapadia SB. Efficient production of antibodies against a mammalian integral membrane protein by phage display. Protein Eng Des Sel 2011;24:679-689.
13. Fofana I, Krieger SE, Grunert F, Glauben S, Xiao F, Fafi-Kremer S, et al. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes. Gastroenterology 2010;139:953-964, 964.e1-4.
14. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B, et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007;446:801-805.